Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of hepatitis C].

D Moradpour1, H E Blum

  • 1Abteilung Innere Medizin II, Medizinische Universitätsklinik Freiburg i. Br. moradpou@ruf.uni-freiburg.de

Praxis
|July 4, 2002
PubMed
Summary

Current Hepatitis C virus (HCV) therapies show limited success. Advances in understanding HCV virology are paving the way for new treatments to improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Journal of viral hepatitis·2018
Same author

Trends in hepatitis C-related mortality in Switzerland.

Journal of viral hepatitis·2017
Same author

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.

Journal of viral hepatitis·2016
Same author

[Hepatitis C: 25 years of progress with still major challenges].

Revue medicale suisse·2015
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.

Alimentary pharmacology & therapeutics·2015

Area of Science:

  • Hepatology
  • Virology
  • Internal Medicine

Background:

  • Hepatitis C virus (HCV) infection is a major global cause of liver disease, including cirrhosis and cancer.
  • Current standard treatments like interferon-alpha and ribavirin have variable efficacy, with lower response rates in genotype 1 infections.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for chronic Hepatitis C virus infection.
  • To highlight recent advancements in understanding HCV molecular virology and pathogenesis.

Main Methods:

  • Literature review of existing and novel therapies for Hepatitis C.
  • Analysis of current treatment response rates based on HCV genotype.

Main Results:

  • Standard therapy (pegylated interferon-alpha and ribavirin) yields sustained response rates of up to 40% for genotype 1 and 80% for genotypes 2 and 3.
  • Recent research has identified new antiviral targets and therapeutic approaches.

Conclusions:

  • Novel therapies are expected to complement current treatments for Hepatitis C.
  • Advancements in virology and pathogenesis research are crucial for developing more effective Hepatitis C treatments.

Related Experiment Videos